CADASIL and other hereditary small vessel diseases of the brain - Increasingly diagnosed conditions underlying familial ischaemic stroke and dementia;CADASIL és egyéb familiáris agyi kisé rbetegségek: Az öröklocombining double acute accentdocombining double acute accent ischaemiás stroke és dementia mind gyakrabban diagnosztizált háttere

Ideggyogyaszati Szemle

Volumn 64, Issue 3-4, 2011, Pages 88-100

  Gunda, Bence ^a,b   Chabriat, Hugues ^a   Bereczki, Dániel ^b  

^a HÔPITAL LARIBOISIÈRE   (France)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

CADASIL; Leukoencephalopathy; MRI; Small vessel disease of the brain; White matter disease

Indexed keywords

NOTCH3 RECEPTOR;

BRAIN DISEASE; BRAIN ISCHEMIA; CADASIL; CENTRAL RETINA VEIN OCCLUSION; CLINICAL PRACTICE; COMORBIDITY; CONFOUNDING VARIABLE; DEMENTIA; DIFFERENTIAL DIAGNOSIS; GENE MUTATION; GENETIC MODEL; HUMAN; MIGRAINE; MOLECULAR PATHOLOGY; MULTIINFARCT DEMENTIA; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; VASCULAR SMOOTH MUSCLE;

ADULT; AGED; BRAIN ISCHEMIA; CADASIL; CEREBROVASCULAR DISORDERS; DIAGNOSIS, DIFFERENTIAL; GENETIC DISEASES, INBORN; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; RECEPTORS, NOTCH; STROKE;

EID: 79954546232     PISSN: 00191442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (116)

1. Sourander P, Walinder J. Hereditary multi-infarct dementia. Morphological and clinical studies of a new disease. Acta Neuropathol 1977;39:247-54.
2. Stevens DL, Hewlett RH, Brownell B. Chronic familial vascular encephalopathy. Lancet 1977;1:1364-5.
3. Colmant HJ, Hagel C, Makrigeorgi-Butera M, Stavrou D. Neuropathology of hereditary subcortical angiopathic encephalopathy. Clin Neuropathol 2000;19:254-5.
4. Groden C, Zeumer H. Subcortical angiopathic encephalopathy: Cerebral small vessel diseases and differential diagnosis on MRI. Clin Neuropathol 2000;19:253.
5. Hagel C, Groden C, Niemeyer R, Stavrou D, Colmant HJ. Subcortical angiopathic encephalopathy in a German kindred suggests an autosomal dominant disorder distinct from CADASIL. Acta Neuropathol 2004;108:231-40. (Pubitemid 39199515)
6. Van Bogaert L. Encéphalopathie sous-corticale progressive (Binswanger) á évolution rapide chez deux soeurs. Med Hellen 1955;24:961-72.
7. Gerhard S. Familiare zerebrale arteriosclerose. Zbl Allg Path Bd 1980;124:63.
8. Tournier-Lasserve E, Joutel A, Melki J, Weissenbach J, Lathrop GM, Chabriat H, et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat Genet 1993;3:256-9. (Pubitemid 23096563)
9. Razvi SS, Davidson R, Bone I, Muir KW. The prevalence of cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) in the west of scotland. J Neurol Neurosurg Psychiatry 2005;76:739-41.
10. Campion D, Dumanchin C, Hannequin D, Dubois B, Belliard S, Puel M, et al. Early-onset autosomal dominant alzheimer disease: Prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet 1999;65:664-70. (Pubitemid 30468710)
11. Harper PS. The epidemiology of Huntington's disease. Hum Genet 1992;89:365-76.
12. Dong Y, Hassan A, Zhang Z, Huber D, Dalageorgou C, Markus HS. Yield of screening for CADASIL mutations in lacunar stroke and leukoaraiosis. Stroke 2003;34:203-5. (Pubitemid 36070823)
13. Sas K VL. CADASIL - egy eset kapcsán. Vascularis Neurológia 2009;1(suppl 1):3.
14. Reményi V. Fiatalkori ischaemiás stroke-szindróma hátterében elocombining double acute accentforduló maternálisan öröklocombining double acute accentdocombining double acute accent valamint monogénes eltérések és szuszceptabilitási gén polimorfizmusok vizsgálata. ELTE diplomamunka. 2009.
15. Nagy Z Virágh S, Bori Z, Óváry C. Novel morphological findings in CADASIL patients. The first Hungarian CADASIL study. Cerebrovasc Dis 2000;10(suppl 2):43.
16. Arima K, Yanagawa S, Ito N, Ikeda S. Cerebral arterial pathology of CADASIL and CARASIL (Maeda syndrome). Neuropathology 2003;23:327-34. (Pubitemid 38004867)
17. Yanagawa S, Ito N, Arima K, Ikeda S. Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy. Neurology 2002;58:817-20. (Pubitemid 34211566)
18. Grand MG, Kaine J, Fulling K, Atkinson J, Dowton SB, Farber M, et al. Cerebroretinal vasculopathy. A new hereditary syndrome. Ophthalmology 1988;95:649-59.
19. Jen J, Cohen AH, Yue Q, Stout JT, Vinters HV, Nelson S, et al. Hereditary endotheliopathy with retinopathy, nephropathy, and stroke (HERNS). Neurology 1997;49:1322-30.
20. Ophoff RA, DeYoung J, Service SK, Joosse M, Caffo NA, Sandkuijl LA, et al. Hereditary vascular retinopathy, cerebroretinal vasculopathy, and hereditary endotheliopathy with retinopathy, nephropathy, and stroke map to a single locus on chromosome 3p21.1-p21.3. Am J Hum Genet 2001;69:447-53. (Pubitemid 32695217)
21. Terwindt GM, Haan J, Ophoff RA, Groenen SM, Storimans CW, Lanser JB, et al. Clinical and genetic analysis of a large Dutch family with autosomal dominant vascular retinopathy, migraine and Raynaud's phenomenon. Brain 1998;121(Pt 2):303-16. (Pubitemid 28075806)
22. Pavlovic AM, Zidverc-Trajkovic J, Milovic MM, Pavlovic DM, Jovanovic Z, Mijajlovic M, et al. Cerebral small vessel disease in pseudoxanthoma elasticum: Three cases. Can J Neurol Sci 2005;32:115-8. (Pubitemid 40363589)
23. Vahedi K, Massin P, Guichard JP, Miocque S, Polivka M, Goutieres F, et al. Hereditary infantile hemiparesis, retinal arteriolar tortuosity, and leukoencephalopathy. Neurology 2003;60:57-63. (Pubitemid 36070644)
24. Verreault S, Joutel A, Riant F, Neves G, Rui Silva M, Maciazek J, et al. A novel hereditary small vessel disease of the brain. Ann Neurol 2006;59:353-7. (Pubitemid 43202489)
25. Low WC, Junna M, Borjesson-Hanson A, Morris CM, Moss TH, Stevens DL, et al. Hereditary multi-infarct dementia of the Swedish type is a novel disorder different from NOTCH 3 causing CADASIL. Brain 2007;130:357-67. (Pubitemid 46181090)
26. Chabriat H, Vahedi K, Iba-Zizen MT, Joutel A, Nibbio A, Nagy TG, , et al. Clinical spectrum of CADASIL: A study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet 1995;346:934-9.
27. Dichgans M, Mayer M, Uttner I, Bruning R, Muller-Hocker J, Rungger G, et al. The phenotypic spectrum of CADASIL: Clinical findings in 102 cases. Ann Neurol 1998;44:731-9. (Pubitemid 28516043)
28. Vahedi K, Chabriat H, Levy C, Joutel A, Tournier-Lasserve E, Bousser MG. Migraine with aura and brain magnetic resonance imaging abnormalities in patients with CADASIL. Arch Neurol 2004;61:1237-40. (Pubitemid 39062677)
29. Opherk C, Peters N, Herzog J, Luedtke R, Dichgans M. Long-term prognosis and causes of death in CADASIL: A retrospective study in 411 patients. Brain 2004;127:2533-9. (Pubitemid 39472981)
30. Mourad A, Levasseur M, Bousser MG, Chabriat H. [CADASIL with minimal symptoms after 60 years]. Rev Neurol (Paris). 2006;162:827-31.
31. Dichgans M. CADASIL: A monogenic condition causing stroke and subcortical vascular dementia. Cerebrovasc Dis 2002;13 Suppl 2:37-41. (Pubitemid 34233907)
32. Chabriat H, Bousser MG. CADASIL. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Adv Neurol 2003;92:147-50.
33. Feuerhake F, Volk B, Ostertag CB, Jungling FD, Kassubek J, Orszagh M, et al. Reversible coma with raised intracranial pressure: An unusual clinical manifestation of CADASIL. Acta Neuropathol 2002;103:188-92. (Pubitemid 36067498)
34. Schon F, Martin RJ, Prevett M, Clough C, Enevoldson TP, Markus HS. "CADASIL coma": An underdiagnosed acute encephalopathy. J Neurol Neurosurg Psychiatry 2003;74:249-52.
35. Tournier-Lasserve E. Cacna1a mutations: Hemiplegic migraine, episodic ataxia type 2, and the others. Neurology 1999;53:3-4. (Pubitemid 29329638)
36. Chabriat H, Tournier-Lasserve E, Vahedi K, Leys D, Joutel A, Nibbio A, et al. Autosomal dominant migraine with MRI white-matter abnormalities mapping to the CADASIL locus. Neurology 1995;45:1086-91.
37. Verin M, Rolland Y, Landgraf F, Chabriat H, Bompais B, Michel A, , et al. New phenotype of the cerebral autosomal dominant arteriopathy mapped to chromosome 19: Migraine as the prominent clinical feature. J Neurol Neurosurg Psychiatry 1995;59:579-85.
38. Peters N, Herzog J, Opherk C, Dichgans M. A two-year clinical follow-up study in 80 CADASIL subjects: Progression patterns and implications for clinical trials. Stroke 2004;35:1603-8. (Pubitemid 38823633)
39. Kumar SK, Mahr G. CADASIL presenting as bipolar disorder. Psychosomatics 1997;38:397-8.
40. Reyes S, Viswanathan A, Godin O, Dufouil C, Benisty S, Hernandez K, et al. Apathy: A major symptom in CADASIL. Neurology 2009;72:905-10.
41. Lagas PA, Juvonen V. Schizophrenia in a patient with cerebral autosomally dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL disease). Nord J Psychiatry 2001;55:41-2. (Pubitemid 32243791)
42. Buffon F, Porcher R, Hernandez K, Kurtz A, Pointeau S, Vahedi K, et al. Cognitive profile in CADASIL. J Neurol Neurosurg Psychiatry 2006;77:175-80. (Pubitemid 43220837)
43. Dichgans M. Cognition in CADASIL. Stroke. 2009;40:S45-7.
44. Peters N, Opherk C, Danek A, Ballard C, Herzog J, Dichgans M. The pattern of cognitive performance in CADASIL: A monogenic condition leading to subcortical ischaemic vascular dementia. Am J Psychiatry 2005;162:2078-85. (Pubitemid 41598261)
45. Baudrimont M, Dubas F, Joutel A, Tournier-Lasserve E, Bousser MG. Autosomal dominant leukoencephalopathy and subcortical ischaemic stroke. A clinicopathological study. Stroke 1993;24:122-5. (Pubitemid 23014394)
46. Choi JC, Kang SY, Kang JH, Park JK. Intracerebral hemorrhages in CADASIL. Neurology 2006;67:2042-4.
47. Van Gerpen JA, Ahlskog JE, Petty GW. Progressive supranuclear palsy phenotype secondary to CADASIL. Parkinsonism Relat Disord 2003;9:367-9. (Pubitemid 36809039)
48. Tournier-Lasserve E, Iba-Zizen MT, Romero N, Bousser MG. Autosomal dominant syndrome with stroke-like episodes and leukoencephalopathy. Stroke 1991;22:1297-302.
49. Choi EJ, Choi CG, Kim JS. Large cerebral artery involvement in CADASIL. Neurology 2005;65:1322-4. (Pubitemid 41508239)
50. Lesnik Oberstein SA, Jukema JW, Van Duinen SG, Macfarlane PW, van Houwelingen HC, Breuning MH, et al. Myocardial infarction in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Medicine (Baltimore) 2003;82:251-6.
51. Chabriat H, Levy C, Taillia H, Iba-Zizen MT, Vahedi K, Joutel A, et al. Patterns of MRI lesions in CADASIL. Neurology 1998;51:452-7. (Pubitemid 28406321)
52. Auer DP, Putz B, Gossl C, Elbel G, Gasser T, Dichgans M. Differential lesion patterns in CADASIL and sporadic subcortical arteriosclerotic encephalopathy: MR imaging study with statistical parametric group comparison. Radiology 2001;218:443-51. (Pubitemid 32121057)
53. Markus HS, Martin RJ, Simpson MA, Dong YB, Ali N, Crosby AH, et al. Diagnostic strategies in CADASIL. Neurology 2002;59:1134-8. (Pubitemid 35192381)
54. O'Sullivan M, Jarosz JM, Martin RJ, Deasy N, Powell JF, Markus HS. MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology 2001;56:628-34. (Pubitemid 32209997)
55. Chabriat H, Mrissa R, Levy C, Vahedi K, Taillia H, Iba-Zizen MT, et al. Brain stem MRI signal abnormalities in CADASIL. Stroke 1999;30:457-9. (Pubitemid 29071817)
56. Gobron C, Viswanathan A, Bousser MG, Chabriat H. Multiple simultaneous cerebral infarctions in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Cerebrovasc Dis 2006;22:445-6. (Pubitemid 44681123)
57. Dichgans M, Holtmannspotter M, Herzog J, Peters N, Bergmann M, Yousry TA. Cerebral microbleeds in CADASIL: A gradient-echo magnetic resonance imaging and autopsy study. Stroke 2002;33:67-71. (Pubitemid 34052187)
58. Cumurciuc R, Guichard JP, Reizine D, Gray F, Bousser MG, Chabriat H. Dilation of Virchow-Robin spaces in CADASIL. Eur J Neurol 2006;13:187-90.
59. Dichgans M, Filippi M, Bruning R, Iannucci G, Berchtenbreiter C, Minicucci L, et al. Quantitative MRI in CADASIL: Correlation with disability and cognitive performance. Neurology 1999;52:1361-7.
60. Jouvent E, Viswanathan A, Mangin JF, O'Sullivan M, Guichard JP, Gschwendtner A, et al. Brain atrophy is related to lacunar lesions and tissue microstructural changes in CADASIL. Stroke 2007;38:1786-90. (Pubitemid 46847248)
61. Peters N, Holtmannspotter M, Opherk C, Gschwendtner A, Herzog J, Samann P, et al. Brain volume changes in CADASIL: A serial MRI study in pure subcortical ischemic vascular disease. Neurology 2006;66:1517-22. (Pubitemid 43958546)
62. Chabriat H. Diffusion histograms in CADASIL. Stroke 2005;36:2526.
63. Chabriat H, Pappata S, Poupon C, Clark CA, Vahedi K, Poupon F, et al. Clinical severity in CADASIL related to ultrastructural damage in white matter: In vivo study with diffusion tensor MRI. Stroke 1999;30:2637-43.
64. Holtmannspotter M, Peters N, Opherk C, Martin D, Herzog J, Bruckmann H, et al. Diffusion magnetic resonance histograms as a surrogate marker and predictor of disease progression in CADASIL: A two-year follow-up study. Stroke 2005;36:2559-65.
65. Molko N, Pappata S, Mangin JF, Poupon C, Vahedi K, Jobert A, et al. Diffusion tensor imaging study of subcortical gray matter in CADASIL. Stroke 2001;32:2049-54. (Pubitemid 32868096)
66. Molko N, Pappata S, Mangin JF, Poupon F, LeBihan D, Bousser MG, Chabriat H. Monitoring disease progression in CADASIL with diffusion magnetic resonance imaging: A study with whole brain histogram analysis. Stroke 2002;33:2902-8.
67. O'Sullivan M, Singhal S, Charlton R, Markus HS. Diffusion tensor imaging of thalamus correlates with cognition in CADASIL without dementia. Neurology 2004;62:702-7. (Pubitemid 38298943)
68. Bruening R, Dichgans M, Berchtenbreiter C, Yousry T, Seelos KC, et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: Decrease in regional cerebral blood volume in hyperintense subcortical lesions inversely correlates with disability and cognitive performance. AJNR Am J Neuroradiol 2001;22:1268-74. (Pubitemid 32734797)
69. Chabriat H, Bousser MG, Pappata S. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: A positron emission tomography study in two affected family members. Stroke 1995;26:1729-30.
70. Mellies JK, Baumer T, Muller JA, Tournier-Lasserve E, Chabriat H, Knobloch O, et al. SPECT study of a German CADASIL family: A phenotype with migraine and progressive dementia only. Neurology 1998;50:1715-21.
71. Tatsch K, Koch W, Linke R, Poepperl G, Peters N, Holtmannspoetter M, Dichgans M. Cortical hypometabolism and crossed cerebellar diaschisis suggest subcortically induced disconnection in CADASIL: An 18F-FDG PET study. J Nucl Med 2003;44:862-9. (Pubitemid 39663395)
72. Tuominen S, Miao Q, Kurki T, Tuisku S, Poyhonen M, Kalimo H, et al. Positron emission tomography examination of cerebral blood flow and glucose metabolism in young CADASIL patients. Stroke 2004;35:1063-7. (Pubitemid 38543518)
73. Chabriat H, Pappata S, Ostergaard L, Clark CA, Pachot-Clouard M, Vahedi K, et al. Cerebral hemodynamics in CADASIL before and after acetazolamide challenge assessed with MRI bolus tracking. Stroke 2000;31:1904-12. (Pubitemid 30620471)
74. 2 reactivity in CADASIL: A transcranial doppler sonography study. Stroke 2001;32:17-21. (Pubitemid 32063818)
75. Jouvent E, Mangin JF, Porcher R, Viswanathan A, O'Sullivan M, Guichard JP, et al. Cortical changes in cerebral small vessel diseases: A 3D MRI study of cortical morphology in CADASIL. Brain 2008;131:2201-8.
76. Kalimo H, Ruchoux MM, Viitanen M, Kalaria RN. CADASIL: A common form of hereditary arteriopathy causing brain infarcts and dementia. Brain Pathol 2002;12:371-84.
77. Miao Q, Paloneva T, Tuominen S, Poyhonen M, Tuisku S, Viitanen M, Kalimo H. Fibrosis and stenosis of the long penetrating cerebral arteries: The cause of the white matter pathology in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Brain Pathol 2004;14:358-64. (Pubitemid 39524964)
78. Okeda R, Arima K, Kawai M. Arterial changes in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) in relation to pathogenesis of diffuse myelin loss of cerebral white matter: Examination of cerebral medullary arteries by reconstruction of serial sections of an autopsy case. Stroke 2002;33:2565-9. (Pubitemid 35266424)
79. Schroder JM, Zuchner S, Dichgans M, Nagy Z, Molnar MJ. Peripheral nerve and skeletal muscle involvement in CADASIL. Acta Neuropathol 2005;110:587-99. (Pubitemid 41763988)
80. Ebke M, Dichgans M, Bergmann M, Voelter HU, Rieger P, Gasser T, Schwendemann G. CADASIL: Skin biopsy allows diagnosis in early stages. Acta Neurol Scand 1997;95:351-7.
81. Ruchoux MM, Chabriat H, Bousser MG, Baudrimont M, Tournier-Lasserve E. Presence of ultrastructural arterial lesions in muscle and skin vessels of patients with CADASIL. Stroke 1994;25:2291-2. (Pubitemid 24338393)
82. Ruchoux MM, Guerouaou D, Vandenhaute B, Pruvo JP, Vermersch P, Leys D. Systemic vascular smooth muscle cell impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Acta Neuropathol 1995;89:500-12.
83. Molnár MJ. Új eredmények a neuromuscularis betegségek molekuláris diagnosztikája és terápiája területén. MTA doktori é rtekezés. 2010.
84. Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, et al NOTCH 3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 1996;383:707-10. (Pubitemid 26360644)
85. Artavanis-Tsakonas S, Rand MD, Lake RJ. NOTCH signaling: Cell fate control and signal integration in development. Science 1999;284:770-6. (Pubitemid 29291335)
86. Prakash N, Hansson E, Betsholtz C, Mitsiadis T, Lendahl U. Mouse NOTCH 3 expression in the pre- and postnatal brain: Relationship to the stroke and dementia syndrome CADASIL. Exp Cell Res 2002;278:31-44. (Pubitemid 34775443)
87. Dichgans M, Herzog J, Gasser T. NOTCH 3 mutation involving three cysteine residues in a family with typical CADASIL. Neurology 2001;57:1714-7. (Pubitemid 33055498)
88. Dichgans M, Ludwig H, Muller-Hocker J, Messerschmidt A, Gasser T. Small in-frame deletions and missense mutations in CADASIL: 3D models predict misfolding of NOTCH 3 EGF-like repeat domains. Eur J Hum Genet 2000;8:280-5. (Pubitemid 30336181)
89. Dotti MT, De Stefano N, Bianchi S, Malandrini A, Battisti C, Cardaioli E, et al. A novel NOTCH 3 frameshift deletion and mitochondrial abnormalities in a patient with CADASIL. Arch Neurol 2004;61:942-5. (Pubitemid 38747338)
90. Joutel A, Chabriat H, Vahedi K, Domenga V, Vayssiere C, Ruchoux MM, et al. Splice site mutation causing a seven amino acid NOTCH 3 in-frame deletion in CADASIL. Neurology 2000;54:1874-5. (Pubitemid 30428427)
91. Peters N, Opherk C, Bergmann T, Castro M, Herzog J, Dichgans M. Spectrum of mutations in biopsy-proven CADASIL: Implications for diagnostic strategies. Arch Neurol 2005;62:1091-4. (Pubitemid 41043729)
92. Joutel A, Favrole P, Labauge P, Chabriat H, Lescoat C, Andreux F, et al. Skin biopsy immunostaining with a NOTCH 3 monoclonal antibody for CADASIL diagnosis. Lancet 2001;358:2049-51. (Pubitemid 34084832)
93. Ruchoux MM, Maurage CA. CADASIL: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. J Neuropathol Exp Neurol 1997;56:947-64
94. Gridley T. NOTCH signaling in vascular development and physiology. Development 2007;134:2709-18. (Pubitemid 47305050)
95. Joutel A, Andreux F, Gaulis S, Domenga V, Cecillon M, Battail N, et al. The ectodomain of the NOTCH 3 receptor accumulates within the cerebrovasculature of CADASIL patients. J Clin Invest 2000;105:597-605.
96. Ishiko A, Shimizu A, Nagata E, Takahashi K, Tabira T, Suzuki N. NOTCH 3 ectodomain is a major component of granular osmiophilic material (GOM) in CADASIL. Acta Neuropathol 2006;112:333-9. (Pubitemid 44275888)
97. Gray F, Polivka M, Viswanathan A, Baudrimont M, Bousser MG, Chabriat H. Apoptosis in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy. J Neuropathol Exp Neurol 2007;66:597-607. (Pubitemid 47051705)
98. Bednarczyk EM, Remler B, Weikart C, Nelson AD, Reed RC. Global cerebral blood flow, blood volume, and oxygen metabolism in patients with migraine headache. Neurology 1998;50:1736-40. (Pubitemid 28283243)
99. Crassard I, Conard J, Bousser MG. Migraine and haemostasis. Cephalalgia 2001;21:630-6.
100. Tzourio C, El Amrani M, Poirier O, Nicaud V, Bousser MG, Alperovitch A. Association between migraine and endothelin type a receptor (ETA -231 a/g) gene polymorphism. Neurology 2001;56:1273-7. (Pubitemid 32455282)
101. Chabriat H, Joutel A, Dichgans M, Tournier-Lasserve E, Bousser MG. CADASIL. Lancet Neurol 2009;8:643-3.
102. Dichgans M, Petersen D. Angiographic complications in CADASIL. Lancet 1997;349:776-7.
103. Cumurciuc R, Massin P, Paques M, Krisovic V, Gaudric A, Bousser MG, et al. Retinal abnormalities in CADASIL: A retrospective study of 18 patients. J Neurol Neurosurg Psychiatry 2004;75:1058-60. (Pubitemid 38869628)
104. Haritoglou C, Rudolph G, Hoops JP, Opherk C, Kampik A, Dichgans M. Retinal vascular abnormalities in CADASIL. Neurology 2004;62:1202-5.
105. Fazekas F. Magnetic resonance signal abnormalities in asymptomatic individuals: Their incidence and functional correlates. Eur Neurol 1989;29:164-8. (Pubitemid 19139398)
106. Schmidt R, Fazekas F, Kleinert G, Offenbacher H, Gindl K, Payer F, et al. Magnetic resonance imaging signal hyperintensities in the deep and subcortical white matter. A comparative study between stroke patients and normal volunteers. Arch Neurol 1992;49:825-7.
107. Swartz RH, Kern RZ. Migraine is associated with magnetic resonance imaging white matter abnormalities: A meta-analysis. Arch Neurol 2004;61:1366-8. (Pubitemid 39202218)
108. Kruit MC, van Buchem MA, Hofman PA, Bakkers JT, Terwindt GM, Ferrari MD, et al. Migraine as a risk factor for subclinical brain lesions. JAMA 2004;291:427-34. (Pubitemid 38129746)
109. Matthews PM, Tampieri D, Berkovic SF, Andermann F, Silver K, Chityat D, Arnold DL. Magnetic resonance imaging shows specific abnormalities in the MELAS syndrome. Neurology 1991;41:1043-6.
110. Costello DJ, Eichler AF, Eichler FS. Leukodystrophies: Classification, diagnosis, and treatment. Neurologist 2009;15:319-28.
111. Chabriat H, Bousser MG. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Handb Clin Neurol 2008;89:671-86.
112. Forteza AM, Brozman B, Rabinstein AA, Romano JG, Bradley WG. Acetazolamide for the treatment of migraine with aura in CADASIL. Neurology 2001;57:2144-5. (Pubitemid 33126897)
113. Weller M, Dichgans J, Klockgether T. Acetazolamide-responsive migraine in CADASIL. Neurology 1998;50:1505.
114. Athwal BS, Lennox GG. Acetazolamide responsiveness in familial hemiplegic migraine. Ann Neurol 1996;40:820-1. (Pubitemid 26415200)
115. Jen JC, Yue Q, Karrim J, Nelson SF, Baloh RW. Spinocerebellar ataxia type 6 with positional vertigo and acetazolamide responsive episodic ataxia. J Neurol Neurosurg Psychiatry 1998;65:565-8. (Pubitemid 28438893)
116. Dichgans M, Markus HS, Salloway S, Verkkoniemi A, Moline M, Wang Q, et al. Donepezil in patients with subcortical vascular cognitive impairment: A randomised double-blind trial in CADASIL. Lancet Neurol 2008;7:310-8.